Specific active immunochemotherapy in lung cancer: a survival study. 1977

T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs

A radomized clinical trial of chemotherapy, immunization and immunochemotherapy among 55 patients with stages I and II carcinoma of the lung is reported. The survival rate in the immunized groups was significantly better (P = 0.001) than that in the nonimmunized groups. The results are discussed in the light of the reactivity of the patients to the specific cancer antigen.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
January 1991, Seminars in surgical oncology,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
April 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
October 1985, Nihon Gan Chiryo Gakkai shi,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
January 1987, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
October 1981, British journal of cancer,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
December 2023, The Thoracic and cardiovascular surgeon,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
June 2002, Journal of epidemiology and community health,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
April 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
May 2020, Journal of thoracic disease,
T H Stewart, and A C Hollinshead, and J E Harris, and S Raman, and R Bélanger, and A Crépeau, and A F Crook, and W E Hirte, and D Hooper, and D J Klaassen, and E F Rapp, and H J Sachs
April 2011, Thorax,
Copied contents to your clipboard!